Robert Bruce Email & Phone Number

Fremont, California, Us

Responsible for all aspects of public and private payer reimbursement strategy and execution for advanced next-generation sequencing (NGS) oncology clinical molecular diagnostic testing, including comprehensive genomic profiling and liquid biopsy MRD assays. Develop and manage internal billing department, including implementation of SaaS revenue cycle management system. Lead public payer (primarily CMS) strategy and tactics to obtain Medicare coverage, coding and appropriate payment for innovative diagnostics. Draft reimbursement dossier and work closely with medical science liaison team on clinical trial design and health economics modeling and publications.

Edison, Nj, Us

Responsible for all aspects of financial control and reporting, risk management, financial analysis and budget planning, and tax preparation and filing for this privately held, venture-funded molecular diagnostics laboratory and medical device company.

Edison, Nj, Us

Responsible for all aspects of public and private reimbursement of molecular diagnostics for colorectal cancer screening and monitoring-focused CLIA-certified laboratory and FDA-regulated medical device manufacturer. Develop and manage internal billing department, including implementation of SaaS revenue cycle management system. Lead public payer (primarily CMS) strategy and tactics to obtain Medicare coverage, coding and appropriate payment for innovative diagnostics. Develop and manage private payer account executive team. Draft reimbursement dossier and work closely with medical science liaison team on clinical trial design and health economics modeling and publications.

Founder/owner/principal of this boutique financial and operational management consulting firm. We focus on providing senior level strategic and tactical advice to privately-owned and publicly-traded companies seeking financing, high growth/commercialization, going through a restructuring or due diligence process, and/or requiring facilitation of complex communications with internal or external stakeholders.

Lihua (formerly NASDAQ: LIWA) was a leading Chinese manufacturer and marketer of alternatives to traditional virgin copper wire, including recycled copper wire, recycled copper rod, recycled copper anode and fine gauge copper-clad aluminum (CCA) wire. Lihua supplied diverse industries in China, including the consumer electronics, automotive, white goods, telecommunications, and wire and cable industries.

Immucell is a publicly traded (NASDAQ: ICCC) manufacturer and marketer of animal health products directed at the bovine (dairy and beef) production industries. Their products include medical devices and pharmaceuticals.

China North East Petroleum Holdings, Ltd. (formerly AMEX: NEP) was a publicly traded oil producer with operations located in northeastern China.

Early employee (first in US) for this Australia and US-based medical device start-up. Enterix developed, manufactured and marketed a novel proprietary colorectal cancer screening test. This included establishing and operating a dedicated national laboratory that processed and reported test results. Led effort to obtain a federal law change that allowed CMS to consider coverage of novel colorectal cancer screening tests, and subsequently obtained a positive National Coverage Decision and appropriate payment for Fecal Immunochemical Testing. Enterix was VC financed (in a difficult market environment) and ultimately was sold to Quest Diagnostics.

Mba, Management

Ba, East Asian Studies

Mandarin Chinese

Mandarin Chinese